Durlax Top Surface IPO vs Medicamen Organics IPO

Comparision between Durlax Top Surface IPO and Medicamen Organics IPO.

IPO Details

Durlax Top Surface IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Medicamen Organics IPO is a SME Book Built Issue proposed to list at NSE SME.

	Durlax Top Surface IPO	Medicamen Organics IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	NSE SME	NSE SME
Lead Managers	Expert Global Consultants Private Limited	GYR Capital Advisors Private Limited
Registrar	Bigshare Services Pvt Ltd	Kfin Technologies Limited
Market Maker	Globalworth Securities Limited	Giriraj Stock Broking Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Durlax Top Surface IPO is up to ₹40.80 Cr whereas the issue size of the Medicamen Organics IPO is up to ₹10.54 Cr. The final issue price of Durlax Top Surface IPO is ₹68.00 per share and of Medicamen Organics IPO is ₹34.00 per share.

	Durlax Top Surface IPO	Medicamen Organics IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹65.00 per share	₹32.00 per share
Issue Price (Upper)	₹68.00 per share	₹34.00 per share
Issue Price (Final)	₹68.00 per share	₹34.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	2000 shares	4000 shares
Fresh Issue Size	42,00,000 shares	31,00,000 shares
Fresh Issue Size (Amount)	up to ₹28.56 Cr	up to ₹10.54 Cr
OFS Issue Size	18,00,000 shares
OFS Issue Size (Amount)	up to ₹12.24 Cr
Issue Size Total	60,00,000 shares	31,00,000 shares
Issue Size Total (Amount)	up to ₹40.80 Cr	up to ₹10.54 Cr

IPO Timetable

Durlax Top Surface IPO opens on Jun 19, 2024, while Medicamen Organics IPO opens on Jun 21, 2024. The closing date of Durlax Top Surface IPO and Medicamen Organics IPO is Jun 21, 2024, and Jun 25, 2024, respectively.

	Durlax Top Surface IPO	Medicamen Organics IPO
Anchor Bid Date	Jun 18, 2024	Jun 20, 2024
Issue Open	Jun 19, 2024	Jun 21, 2024
Issue Close	Jun 21, 2024	Jun 25, 2024
Basis Of Allotment (Tentative)	Jun 24, 2024	Jun 26, 2024
Initiation of Refunds (Tentative)	Jun 25, 2024	Jun 27, 2024
Credit of Share (Tentative)	Jun 25, 2024	Jun 27, 2024
Listing date (Tentative)	Jun 26, 2024	Jun 28, 2024
Anchor Lockin End date 1	Jul 24, 2024	Jul 26, 2024
Anchor Lockin End date 2	Sep 22, 2024	Sep 24, 2024

Financials

Durlax Top Surface IPO P/E ratio is 16.73, as compared to Medicamen Organics IPO P/E ratio of 30.53.

Durlax Top Surface IPO

Medicamen Organics IPO

Financial

Durlax Top Surface Limited Financial Information (Restated)

Durlax Top Surface Limited's revenue increased by 35.9% and profit after tax (PAT) rose by 141.15% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	10,553.50	7,673.02	7,168.11
Revenue	9,083.93	6,684.20	4,741.81
Profit After Tax	505.07	209.44	48.42
Net Worth	2,184.38	1,671.21	1,292.27
Reserves and Surplus	941.61	431.14	1,277.29
Total Borrowing	6,070.71	3,690.93	3,929.82
Amount in ₹ Lakhs

Medicamen Organics Limited Financial Information (Restated)

Medicamen Organics Limited's revenue increased by 10.13% and profit after tax (PAT) rose by 151% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	3,858.07	3,211.98	2,707.21	2,634.37
Revenue	2,528.96	2,296.24	2,118.67	2,505.96
Profit After Tax	240.41	95.78	9.23	29.81
Net Worth	1,518.40	851.71	755.92	746.72
Reserves and Surplus	658.40	251.71	155.92	146.72
Total Borrowing	1,265.65	1,179.50	1,024.57	958.97
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

95.44%

81.21%

Promoter Shareholding (Post-Issue)

60.35%

P/E Ratio

16.73

30.53

Market Cap

₹113.07 Cr.

₹39.78 Cr.

ROE

26.20%%

19.90%%

ROCE

20.20%%

14.50%%

Debt/Equity

2.78

0.83

EPS

₹4.06

₹1.11

RoNW

23.12%%

15.83%

Shares Offered

In the Durlax Top Surface IPO retail investors (RII) are offered 20,00,000 shares while in Medicamen Organics IPO retail investors are offered 20,00,000 shares. Qualified institutional buyers (QIB) are offered 22,52,000 shares in Durlax Top Surface IPO and 5,84,000 shares in Medicamen Organics IPO.

	Durlax Top Surface IPO	Medicamen Organics IPO
Anchor Investor Reserveration	5,92,000 shares	8,76,000 shares
Market Maker Reserveration	3,00,000 shares	1,72,000 shares
QIB	22,52,000 shares	5,84,000 shares
NII	8,56,000 shares	4,40,000 shares
RII	20,00,000 shares	10,28,000 shares
Employee	0 shares	0 shares
Others
Total	51,08,000 shares	20,52,000 shares

Bids Received (Subscription)

Durlax Top Surface IPO subscribed 166.79x in total, whereas Medicamen Organics IPO subscribed 993.56x.

	Durlax Top Surface IPO	Medicamen Organics IPO
QIB (times)	48.29x	173.03x
NII (times)	415.06x	1,343.83x
Big NII (times)
Small NII (times)
RII (times)	193.95x	1,309.77x
Employee (times)
Other (times)
Total (times)	166.79x	993.56x

Compare with others

Durlax Top Surface IPO	Medicamen Organics IPO
The Money Fair IPO	Sylvan Plyboard IPO
Winny Immigration IPO	Shivalic Power Control IPO
Medicamen Organics IPO	Divine Power IPO
EnNutrica IPO	The Money Fair IPO
Falcon Technoprojects India IPO	Winny Immigration IPO
GEM Enviro IPO	EnNutrica IPO
GPES Solar IPO	Falcon Technoprojects India IPO
United Cotfab IPO	Durlax Top Surface IPO
3C IT IPO	GEM Enviro IPO
Magenta Lifecare IPO	GPES Solar IPO

Comments

Add a public comment...